SCIB.ST
SciBase Holding AB (publ) [SCIB.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SCIB.ST Stock Summary
Top 10 Correlated ETFs
SCIB.ST
Top 10 Correlated Stocks
SCIB.ST
In the News
SCIB.ST Financial details
Company Rating
-
Market Cap
47.21M
Income
-55.58M
Revenue
23.25M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
27
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-1.17
Forward P/E
-
PEG
-3.33
P/S
4.86
P/B
1.81
P/C
-
P/FCF
-2.19
Quick Ratio
3.49
Current Ratio
4.03
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.59
EPS next Y
-
EPS next Q
-
EPS this Y
-10.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-18.52%
Revenue last 5Y
20.17%
Revenue Q/Q
-20.47%
EPS Q/Q
54.55%
-
-
-
-
SMA20
-7.14%
SMA50
-
SMA100
5.41%
Inst Own
-
Inst Trans
-
ROA
-111%
ROE
-152%
ROC
-0.16%
Gross Margin
66%
Oper. Margin
-47%
Profit Margin
-414%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.281-1.954
52W High
-
52W Low
-
RSI
45.16
Rel Volume
0.02
Avg Volume
324.44K
Volume
7.14K
Perf Week
-3.54%
Perf Month
-9.29%
Perf Quarter
-19.96%
Perf Half Y
-20.95%
-
-
-
-
Beta
1.492
-
-
Volatility
0.01%, 0.02%
Prev Close
0%
Price
0.381
Change
-2.56%
Company Profile
- Volume Average 324.44K
- Market Capitalization 47.21M
- Employee 27
- CEO Ms. Pia Renaudin
- Headquarters Sundbyberg,SE
- IPO Date 2015-06-02
-
Website
https://www.scibase.com 
SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions in Europe and internationally. Its product includes Nevisense and Nevisense Go, a point of care platform that addresses in the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. The company has a collaboration agreement with Advanced Dermatology and Cosmetic Surgery (ADCS) group. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.
